Sanjay K. Garg
North Terrace
Adelaide, SA 5000, Australia
Adelaide, SA 5000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
Vaginal drug delivery for precision therapy in polyendocrine metabolic ovarian syndrome: emerging technologies, translational challenges and future perspectives.
Journal: Expert opinion on drug delivery
Published: August 31, 2026
Development and in vivo pharmacokinetic evaluation of a phospholipid complex self-nanoemulsifying drug delivery system (PLC-SNEDDS) for enhanced oral bioavailability of cannabidiol.
Journal: Drug delivery
Published: July 23, 2026
Development of Cannabidiol-Loaded PLGA Microspheres for Long-Acting Injectable Delivery: Evaluation of Poly(2-ethyl-2-oxazoline) as an Alternative to Poly(ethylene glycol).
Journal: Pharmaceutics
Published: February 03, 2026
3D printed biodegradable bilayer films: a promising frontier in liver cancer therapy.
Journal: Expert opinion on drug delivery
Published: October 27, 2025
Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells.
Journal: Frontiers in drug delivery
Published: October 18, 2025
A pH-sensitive dual-encapsulating delivery system: Chitosan-alginate hydrogels trapping glycyrrhizic acid/curcumin micelles for synergistic ulcerative colitis.
Journal: International journal of biological macromolecules
Published: August 15, 2025
Pharmaceutical Formulations and Analytical Methods of Donepezil.
Journal: AAPS PharmSciTech
Published: August 15, 2025
Development of Timed Release Vaginal Mucosal Cloprostenol for Farrowing Management in Sows.
Journal: Pharmaceutics
Published: August 14, 2025
Evaluation of Permeation Enhancers for Vaginal Delivery of Buserelin Acetate Using a Validated Chromatographic Method and Ex Vivo Porcine Model.
Journal: Pharmaceutics
Published: August 13, 2025
Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa.
Journal: Pharmaceutics
Published: August 01, 2025
Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.
Journal: International journal of molecular sciences
Published: July 07, 2025
Last Updated: 09/26/2026